A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study

Area of Science:

• Endocrinology
• Medical Informatics
• Digital Health

Background:

• Current telemedicine systems for diabetes collect extensive patient data but often fail to meet treatment goals.
• A significant percentage of patients struggle to achieve established diabetes management targets despite available technologies.

Purpose of the Study:

• To evaluate the therapeutic benefits of the Diani telemedicine system in managing type 1 diabetes mellitus.
• Assess the impact of a real-time diabetes diary app on patient outcomes and disease management.

Main Methods:

• A 24-week feasibility study involving 10 patients with type 1 diabetes.
• Utilized the WHOQOL-BREF questionnaire and system evaluation questionnaires.
• Monitored glycated hemoglobin (HbA1c), body weight, system usage, and physical activity via a real-time app and Diani server.

Main Results:

• Mean HbA1c decreased by 4.35 mmol/mol (P=.01) after the intervention.
• Daily app usage averaged 18.6 minutes; 30% increase in patients measuring blood glucose thrice daily.
• Patients positively evaluated data visualization, automatic glucometer transmission, and device compatibility.

Conclusions:

• The Diani system demonstrated significant benefits for type 1 diabetes management.
• Patients reported increased diabetes knowledge and better understanding of how measured values impact disease control.
• The system positively influenced HbA1c levels, indicating improved glycemic control.